Didier Payen

Active 1984–2025

105
Papers
26,519
Citations
81
h-index
103
i10-index

Citations

Citations per year for Didier Payen1973: 1 citations1978: 3 citations1985: 1 citations1986: 2 citations1987: 1 citations1988: 1 citations1991: 1 citations1992: 2 citations1993: 2 citations1994: 2 citations1995: 6 citations1996: 4 citations1997: 11 citations1998: 10 citations1999: 17 citations2000: 23 citations2001: 15 citations2002: 31 citations2003: 24 citations2004: 26 citations2005: 50 citations2006: 53 citations2007: 62 citations2008: 78 citations2009: 151 citations2010: 154 citations2011: 162 citations2012: 171 citations2013: 224 citations2014: 278 citations2015: 291 citations2016: 283 citations2017: 270 citations2018: 236 citations2019: 815 citations2020: 858 citations2021: 810 citations2022: 553 citations2023: 419 citations2024: 607 citations2025: 325 citations2026: 13 citations1974–1977: no citations, so these years are not shown1979–1984: no citations, so these years are not shown1989–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,082 citing papers, 19.6% of this breakdownChina: 1,012 citing papers, 9.5% of this breakdownFrance: 815 citing papers, 7.7% of this breakdownUnited Kingdom: 710 citing papers, 6.7% of this breakdownGermany: 584 citing papers, 5.5% of this breakdownItaly: 476 citing papers, 4.5% of this breakdownNetherlands: 449 citing papers, 4.2% of this breakdownCanada: 434 citing papers, 4.1% of this breakdownAustralia: 347 citing papers, 3.3% of this breakdownBelgium: 320 citing papers, 3% of this breakdownSpain: 269 citing papers, 2.5% of this breakdownJapan: 232 citing papers, 2.2% of this breakdown
0%19.6%Other 27.2%

Fields

  • Medicine74.3%
  • Immunology and Microbiology11%
  • Biochemistry, Genetics and Molecular Biology8%
  • Engineering2%
  • Nursing1.3%
  • Neuroscience1.1%
  • Other2.3%

Topics

  • Sepsis Diagnosis and Treatment13.8%
  • Immune Response and Inflammation5.4%
  • Acute Kidney Injury Research4.6%
  • Hemodynamic Monitoring and Therapy4%
  • Trauma, Hemostasis, Coagulopathy, Resuscitation3.4%
  • Intensive Care Unit Cognitive Disorders2.3%
  • Other66.5%

Coauthors

All papers

Open in search
  1. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

    Authors: , , - Nature reviews. Immunology 2013 cited by 2,649

  2. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach

    Authors: , , - The Lancet Infectious Diseases 2013 cited by 1,434

  3. Sepsis in European intensive care units: Results of the SOAP study*

    Authors: , , , , , , , , , - Critical Care Medicine 2006 cited by 2,856

  4. Drotrecogin Alfa (Activated) in Adults with Septic Shock

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,282

  5. Hydrocortisone Therapy for Patients with Septic Shock

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 2,109

  6. A Unified Theory of Sepsis-Induced Acute Kidney Injury

    Authors: , , , , , , - Shock 2013 cited by 767

  7. Second consensus on the assessment of sublingual microcirculation in critically ill patients: results from a task force of the European Society of Intensive Care Medicine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2018 cited by 483

  8. Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2018 cited by 174

  9. Current use of vasopressors in septic shock

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Tilma Vistisen, Iwan C.C. van der Horst, Jean‐Louis Vincent, Jean–Louis Teboul - Annals of Intensive Care 2019 cited by 197

  10. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial

    Authors: , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2015 cited by 399

  11. Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series

    Authors: , , , , , , , , - BMC Infectious Diseases 2019 cited by 140

  12. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study

    Authors: , , , , , , - Critical Care 2013 cited by 479

  13. Bench-to-bedside review: Glucose and stress conditions in the intensive care unit

    Authors: , , - Critical Care 2010 cited by 158

  14. Understanding Lactatemia in Human Sepsis. Potential Impact for Early Management

    Authors: , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 173

  15. Enhancing sepsis biomarker development: key considerations from public and private perspectives

    Authors: , , , , , , , , , , - Critical Care 2024 cited by 79

  16. Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: relation with secondary infections

    Authors: , , , , , - Annals of Intensive Care 2022 cited by 55

  17. Immune Cell Phenotype and Function in Sepsis

    Authors: , , , , , , , - Shock 2015 cited by 200

  18. A positive fluid balance is associated with a worse outcome in patients with acute renal failure

    Authors: , , , , , - Critical Care 2008 cited by 954

  19. Current use of inotropes in circulatory shock

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Radermacher, Daniel A. Reuter, Yasser Sakr, Michael Sander, Bernd Saugel, Mervyn Singer, Pierre Squara, Antoine Vieillard‐Baron, Philippe Vignon, Jean‐Louis Vincent, Iwan C.C. van der Horst, Simon Tilma Vistisen, Jean–Louis Teboul - Annals of Intensive Care 2021 cited by 66

  20. CXCL5-mediated recruitment of neutrophils into the peritoneal cavity of Gdf15 -deficient mice protects against abdominal sepsis

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 62

  21. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies

    Authors: , , , , - Current Opinion in Immunology 2013 cited by 220

  22. High plasma level of S100A8/S100A9 and S100A12 at admission indicates a higher risk of death in septic shock patients

    Authors: , , , , , , , , , - Scientific Reports 2019 cited by 82

  23. International Study on Microcirculatory Shock Occurrence in Acutely Ill Patients*

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter E. Spronk, Shaman Jhanji, Sheena Hubble, Marialuisa Chierego, Christian Jung, Daniel Martín, Carlo Sorbara, Jan G.P. Tijssen, Jan Bakker, Can İnce - Critical Care Medicine 2014 cited by 156

  24. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications

    Authors: , , , , , , , , , , , , , , , , , - Critical Care 2016 cited by 116